GCP
VYGR icon

GSA Capital Partners’s Voyager Therapeutics VYGR Stock Holding History

GSA Capital Partners’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-184,203
Closed -$860K – 2127
2025
Q3 		$860K Sell
184,203
-40,426
-18% -$146K 0.07% 504
2025
Q2 		$699K Buy
+224,629
New +$725K 0.05% 691
2025
Q1 		– Sell
-123,459
Closed -$700K – 2112
2024
Q4 		$700K Buy
+123,459
New +$796K 0.05% 656
2021
Q4 		– Sell
-234,981
Closed -$618K – 1837
2021
Q3 		$618K Sell
234,981
-11,023
-4% -$35.8K 0.06% 566
2021
Q2 		$1.02M Buy
246,004
+180,058
+273% +$816K 0.11% 246
2021
Q1 		$311K Buy
+65,946
New +$450K 0.05% 626
2020
Q2 		– Sell
-14,425
Closed -$132K – 1145
2020
Q1 		$132K Sell
14,425
-34,399
-70% -$395K 0.03% 852
2019
Q4 		$681K Buy
48,824
+24,094
+97% +$350K 0.08% 447
2019
Q3 		$426K Buy
+24,730
New +$519K 0.06% 653
2019
Q2 		– Sell
-19,178
Closed -$367K – 1761
2019
Q1 		$367K Sell
19,178
-15,022
-44% -$196K 0.04% 877
2018
Q4 		$321K Buy
+34,200
New +$439K 0.04% 798
2018
Q3 		– Sell
-30,400
Closed -$594K – 1927
2018
Q2 		$594K Buy
+30,400
New +$601K 0.03% 1072

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GSA Capital Partners's VYGR Position: Q4 2025 in Review

GSA Capital Partners sold out of Voyager Therapeutics (VYGR) in Q4 2025, closing a stake of 184,203 shares — an estimated $860K sold.

GSA Capital Partners first reported a position in VYGR in Q2 2018 and held it in 12 quarters. The position peaked at $1.02M in Q2 2021. 125 funds tracked by Wall St. Rank hold VYGR as of Q4 2025.

  • GSA Capital Partners reported no remaining Voyager Therapeutics position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 184,203 Voyager Therapeutics shares in Q4 2025, an estimated $860K.
  • GSA Capital Partners first reported a position in Voyager Therapeutics in Q2 2018 and held it in 12 quarters.
  • GSA Capital Partners's Voyager Therapeutics position peaked at $1.02M in Q2 2021.
  • 125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.